Anterior visual system imaging to investigate energy failure in multiple sclerosis.


Journal

Brain : a journal of neurology
ISSN: 1460-2156
Titre abrégé: Brain
Pays: England
ID NLM: 0372537

Informations de publication

Date de publication:
01 07 2020
Historique:
received: 25 06 2019
revised: 26 11 2019
accepted: 24 12 2019
pubmed: 13 3 2020
medline: 31 12 2020
entrez: 13 3 2020
Statut: ppublish

Résumé

Mitochondrial failure and hypoxia are key contributors to multiple sclerosis pathophysiology. Importantly, improving mitochondrial function holds promise as a new therapeutic strategy in multiple sclerosis. Currently, studying mitochondrial changes in multiple sclerosis is hampered by a paucity of non-invasive techniques to investigate mitochondrial function of the CNS in vivo. It is against this backdrop that the anterior visual system provides new avenues for monitoring of mitochondrial changes. The retina and optic nerve are among the metabolically most active structures in the human body and are almost always affected to some degree in multiple sclerosis. Here, we provide an update on emerging technologies that have the potential to indirectly monitor changes of metabolism and mitochondrial function. We report on the promising work with optical coherence tomography, showing structural changes in outer retinal mitochondrial signal bands, and with optical coherence angiography, quantifying retinal perfusion at the microcapillary level. We show that adaptive optics scanning laser ophthalmoscopy can visualize live perfusion through microcapillaries and structural changes at the level of single photoreceptors and neurons. Advantages and limitations of these techniques are summarized with regard to future research into the pathology of the disease and as trial outcome measures.

Identifiants

pubmed: 32163545
pii: 5804129
doi: 10.1093/brain/awaa049
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

1999-2008

Informations de copyright

© The Author(s) (2020). Published by Oxford University Press on behalf of the Guarantors of Brain. All rights reserved. For permissions, please email: journals.permissions@oup.com.

Auteurs

Iris Kleerekooper (I)

Department of Neuroinflammation, UCL Institute of Neurology, Queen Square, London, UK.
The National Hospital for Neurology and Neurosurgery, Queen Square, London, UK.
Moorfields Eye Hospital, City Road, London, UK.

Axel Petzold (A)

Department of Neuroinflammation, UCL Institute of Neurology, Queen Square, London, UK.
The National Hospital for Neurology and Neurosurgery, Queen Square, London, UK.
Moorfields Eye Hospital, City Road, London, UK.
Dutch Expertise Centre Neuro-ophthalmology and MS Centre Amsterdam, Amsterdam University Medical Centre, Amsterdam, The Netherlands.

S Anand Trip (SA)

Department of Neuroinflammation, UCL Institute of Neurology, Queen Square, London, UK.
The National Hospital for Neurology and Neurosurgery, Queen Square, London, UK.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH